Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;37(4):2111-5.
doi: 10.1007/s11033-009-9676-2. Epub 2009 Aug 9.

Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment

Affiliations

Pro-inflammatory cytokines of rat vasculature in DOCA-salt treatment

Behjat Seifi et al. Mol Biol Rep. 2010 Apr.

Abstract

The purpose of this study was to ascertain the onset expression of pro-inflammatory cytokines in the aorta and kidney and establish their correlation with the increase in arterial blood pressure in rats subjected to DOCA-salt treatment. Male Sprague-Dawley rats underwent unilateral nephrectomy and received subcutaneous DOCA (20 mg/rat/week) as well as 1% NaCl and 0.2% KCl for drinking for 2 weeks. Blood pressure and expression of pro-inflammatory cytokines in aorta and kidney were studied weekly during the induction of hypertension. The treated rats exhibited a mild elevation of blood pressure at 1 week and a profound increase at 2 weeks. Quantitative RT-PCR demonstrated a 4.9-fold and a 3.6-fold enhancement in the expression of TNF-alpha and IL-6, respectively, in aorta as early as 1 week. The expression of IL-6 and TNF-alpha in the kidney remained almost unchanged at 1 week but mildly increased at 2 weeks DOCA-salt treatment. This study indicates a robust increase in the expression of IL-6 and TNF-alpha in aorta in DOCA-salt treated rats. This enhancement suggests that the activation of pro-inflammatory cytokines may contribute to onset of the elevation of blood pressure in DOCA-salt hypertension model.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Time course of systolic blood pressure elevation in rats on DOCA-salt treatment. The data are presented as mean ± SEM. * P < 0.05 compared to sham-operated, # P < 0.05 compared to first week
Fig. 2
Fig. 2
Expression of IL-6 and TNF-α in aorta of rats on DOCA and/or salt treatment. a IL-6 and TNF-α expression by RT-PCR in DOCA-salt treatment. b IL-6 and TNF-α expression by RT-PCR in DOCA or salt treatment. c Fold change in the expression of IL-6 and TNF-α in DOCA-salt treatment

Similar articles

Cited by

References

    1. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS (2008) Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 31:515–523. doi:10.1291/hypres.31.515 - DOI - PubMed
    1. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND (2005) Early and sustained inhibition of nuclear factor-kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 315:51–57. doi:10.1124/jpet.105.088062 - DOI - PubMed
    1. Obst M, Gross V, Luft FC (2004) Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice. J Hypertens 22:1889–1894. doi:10.1097/00004872-200410000-00010 - DOI - PubMed
    1. Elmarakby AA, Quigley JE, Pollock DM, Imig JD (2006) Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47:557–562. doi:10.1161/01.HYP.0000198545.01860.90 - DOI - PubMed
    1. Guzik TJ, Hoch NE, Brown KA et al. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460. doi:10.1084/jem.20070657 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources